BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36858312)

  • 1. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
    Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
    Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.
    Xing Y; Sun X; Li F; Jiang X; Jiang A; Li X; Lv R; Shao L
    J Int Med Res; 2021 Jun; 49(6):3000605211013548. PubMed ID: 34187214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
    Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression.
    Feng Y; Dong Y; Rao B; Yu Y; Su W; Zeng J; Zhao E; Chen Y; Fang S; Zhou Y; Lu J; Qiu F
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14927-14940. PubMed ID: 37603104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis.
    Xu S; Jia G; Zhang H; Wang L; Cong Y; Lv M; Xu J; Ruan H; Jia X; Xu P; Wang Y
    Life Sci; 2021 Jan; 264():118636. PubMed ID: 33148416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
    Luo A; Lan X; Qiu Q; Zhou Q; Li J; Wu M; Liu P; Zhang H; Lu B; Lu Y; Lu W
    Cell Death Dis; 2022 Nov; 13(11):936. PubMed ID: 36344495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth.
    Huang JZ; Chen M; Chen D; Gao XC; Zhu S; Huang H; Hu M; Zhu H; Yan GR
    Mol Cell; 2017 Oct; 68(1):171-184.e6. PubMed ID: 28985503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA HOTTIP enhances the fibrosis of lung tissues by regulating the miR‑744‑5p/PTBP1 signaling axis.
    Li J; Chai W; Zhao Z; Zhou Y; Wu Q
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of β-catenin.
    Jiang W; Ou ZL; Zhu Q; Yao YB; Zai HY
    Pathol Res Pract; 2022 Apr; 232():153829. PubMed ID: 35255389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
    Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
    Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ZMIZ1-AS1 promotes osteosarcoma progression by stabilization of ZMIZ1.
    Zhou Y; Jin Q; Chang J; Zhao Z; Sun C
    Cell Biol Toxicol; 2022 Dec; 38(6):1013-1026. PubMed ID: 34508303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia.
    Wu C; Cui J; Huo Y; Shi L; Wang C
    Int J Biol Macromol; 2023 May; 237():123990. PubMed ID: 36906205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors.
    Wu H; Ye J; Zhang M; Luo H
    J Cancer; 2024; 15(3):714-728. PubMed ID: 38213732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
    Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
    FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowly expressed lncRNA PVT1 suppresses proliferation and advances apoptosis of glioma cells through up-regulating microRNA-128-1-5p and inhibiting PTBP1.
    Dahai Z; Daliang C; Famu L; Xiang W; Lenian L; Jianmin C; Xiaobing X
    Brain Res Bull; 2020 Oct; 163():1-13. PubMed ID: 32562719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
    Zhao R; Song J; Jin Y; Liu Y
    J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
    Papaioannou D; Petri A; Dovey OM; Terreri S; Wang E; Collins FA; Woodward LA; Walker AE; Nicolet D; Pepe F; Kumchala P; Bill M; Walker CJ; Karunasiri M; Mrózek K; Gardner ML; Camilotto V; Zitzer N; Cooper JL; Cai X; Rong-Mullins X; Kohlschmidt J; Archer KJ; Freitas MA; Zheng Y; Lee RJ; Aifantis I; Vassiliou G; Singh G; Kauppinen S; Bloomfield CD; Dorrance AM; Garzon R
    Nat Commun; 2019 Nov; 10(1):5351. PubMed ID: 31767858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.